Headlines about Mesoblast Limited (NASDAQ:MESO) have been trending somewhat positive this week, according to Accern Sentiment. The research group rates the sentiment of press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Mesoblast Limited earned a news sentiment score of 0.21 on Accern’s scale. Accern also gave news headlines about the company an impact score of 46.8747768989543 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
Here are some of the media stories that may have impacted Accern Sentiment Analysis’s rankings:
- Mesoblast Limited (MESO) to Post FY2018 Earnings of ($0.80) Per Share, Cantor Fitzgerald Forecasts (americanbankingnews.com)
- Financial Review: Mesoblast Limited (MESO) vs. Its Peers (americanbankingnews.com)
- Mesoblast Limited (MESO) Given a $16.00 Price Target by Oppenheimer Holdings, Inc. Analysts (americanbankingnews.com)
- Maxim Group Analysts Give Mesoblast Limited (MESO) a $14.00 Price Target (americanbankingnews.com)
- Zacks Investment Research Lowers Mesoblast Limited (MESO) to Strong Sell (americanbankingnews.com)
A number of equities research analysts have recently weighed in on MESO shares. Oppenheimer Holdings, Inc. set a $16.00 price target on shares of Mesoblast Limited and gave the company a “buy” rating in a research report on Tuesday, November 14th. Zacks Investment Research downgraded shares of Mesoblast Limited from a “hold” rating to a “strong sell” rating in a research report on Thursday, November 16th. Maxim Group set a $14.00 price target on shares of Mesoblast Limited and gave the company a “buy” rating in a research report on Wednesday, November 15th. Cantor Fitzgerald reissued a “buy” rating on shares of Mesoblast Limited in a research note on Wednesday, August 23rd. Finally, ValuEngine cut shares of Mesoblast Limited from a “hold” rating to a “sell” rating in a research note on Friday, September 15th. Three analysts have rated the stock with a sell rating, two have issued a hold rating and four have issued a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $13.14.
Shares of Mesoblast Limited (NASDAQ MESO) opened at $5.00 on Friday. Mesoblast Limited has a 52-week low of $4.39 and a 52-week high of $12.50.
About Mesoblast Limited
Receive News & Ratings for Mesoblast Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast Limited and related companies with MarketBeat.com's FREE daily email newsletter.